Stock listing
Frankfurt:ON4 ONO Pharmaceutical Co., Ltd. Aktie
German listing (Frankfurt) of ONO Pharmaceutical Co., Ltd. · home listing Tokyo:4528
Follow ONO Pharmaceutical Co., Ltd. into a list and get an email when it puts out news.
Share price · FWB:ON4
€13.47 EUR -0.13 (-1.0%)
Close on Nov 20, 2026
- Day range
- €13.44 – €13.47 EURNov 20, 2026
- Market cap
- €6.33B EURAt the close on Nov 20, 2026 · price × 469.9M shares outstanding
- 52-week range
- €11.24 – €14.42 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €96 EURMedian day 0 shares · 51 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:OPHLY | $5.14 USD | +0.01 (+0.2%) | 200 | $5.22 | $5.22 | $5.14 | $5.13 | Close on Nov 20, 2026 |
| Frankfurt:ON4 | €13.47 EUR | -0.13 (-1.0%) | — | €13.44 | €13.47 | €13.44 | €13.60 | Close on Nov 20, 2026 |
| Munich:ON4 | €13.72 EUR | -0.655 (-4.6%) | — | €14.05 | €14.05 | €13.72 | €14.37 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:ON4 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €12.73 | -0.563 | -4.2% | €12.61 | €12.73 | €12.60 | 0 | |
| €13.29 | +0.494 | +3.9% | €13.29 | €13.30 | €13.29 | 0 | |
| €12.80 | +0.383 | +3.1% | €12.80 | €12.80 | €12.80 | 0 | |
| €12.41 | -0.08 | -0.6% | €12.43 | €12.49 | €12.39 | 0 | |
| €12.49 | +0.159 | +1.3% | €12.51 | €12.52 | €12.49 | 0 | |
| €12.33 | +0.284 | +2.4% | €12.28 | €12.39 | €12.22 | 0 | |
| €12.05 | -1.369 | -10.2% | €12.09 | €12.13 | €12.00 | 180 | |
| €13.42 | +0.086 | +0.6% | €13.55 | €13.56 | €13.42 | 0 | |
| €13.33 | -0.228 | -1.7% | €13.33 | €13.35 | €13.29 | 0 | |
| €13.56 | -0.026 | -0.2% | €13.56 | €13.63 | €13.52 | 70 | |
| €13.59 | +0.072 | +0.5% | €13.58 | €13.59 | €13.58 | 2 | |
| €13.51 | -0.078 | -0.6% | €13.56 | €13.64 | €13.51 | 0 | |
| €13.59 | +0.122 | +0.9% | €13.56 | €13.60 | €13.43 | 0 | |
| €13.47 | +0.349 | +2.7% | €13.43 | €13.48 | €13.33 | 0 | |
| €13.12 | +0.198 | +1.5% | €13.22 | €13.27 | €13.03 | 0 | |
| €12.92 | +0.271 | +2.1% | €12.94 | €13.01 | €12.87 | 0 | |
| €12.65 | +0.498 | +4.1% | €12.66 | €12.71 | €12.64 | 0 | |
| €12.15 | -0.251 | -2.0% | €12.15 | €12.17 | €12.08 | 0 | |
| €12.41 | +0.236 | +1.9% | €12.41 | €12.45 | €12.36 | 0 | |
| €12.17 | +0.034 | +0.3% | €12.16 | €12.26 | €12.13 | 0 | |
| €12.14 | -0.063 | -0.5% | €12.11 | €12.17 | €12.10 | 0 | |
| €12.20 | +0.019 | +0.2% | €12.21 | €12.21 | €12.07 | 0 | |
| €12.18 | -0.077 | -0.6% | €12.13 | €12.18 | €12.10 | 0 | |
| €12.26 | -0.137 | -1.1% | €12.29 | €12.31 | €12.19 | 0 | |
| €12.39 | +0.082 | +0.7% | €12.45 | €13.53 | €12.36 | 50 | |
| €12.31 | -0.215 | -1.7% | €12.28 | €12.46 | €12.26 | 0 | |
| €12.53 | 0.00 | 0.0% | €12.43 | €12.57 | €12.43 | 0 | |
| €12.53 | +0.04 | +0.3% | €12.53 | €12.56 | €12.52 | 0 | |
| €12.49 | -0.295 | -2.3% | €12.48 | €12.52 | €12.46 | 0 | |
| €12.78 | -0.16 | -1.2% | €12.75 | €13.02 | €12.74 | 0 | |
| €12.94 | +0.193 | +1.5% | €12.87 | €13.00 | €12.84 | 0 | |
| €12.75 | +0.015 | +0.1% | €12.76 | €12.77 | €12.72 | 0 | |
| €12.73 | +0.104 | +0.8% | €12.73 | €12.76 | €12.64 | 0 | |
| €12.63 | +0.025 | +0.2% | €12.63 | €12.64 | €12.61 | 0 | |
| €12.60 | +0.011 | +0.1% | €12.61 | €12.61 | €12.56 | 0 | |
| €12.59 | -0.177 | -1.4% | €12.60 | €12.62 | €12.56 | 0 | |
| €12.77 | +0.281 | +2.2% | €12.80 | €12.81 | €12.76 | 0 | |
| €12.49 | -0.081 | -0.6% | €12.52 | €12.53 | €12.42 | 0 | |
| €12.57 | -0.201 | -1.6% | €12.58 | €12.58 | €12.53 | 0 | |
| €12.77 | -0.727 | -5.4% | €12.56 | €12.77 | €12.56 | 0 | |
| €13.50 | +0.795 | +6.3% | €12.86 | €13.69 | €12.85 | 50 | |
| €12.70 | -0.171 | -1.3% | €13.00 | €13.08 | €12.59 | 0 | |
| €12.87 | -0.38 | -2.9% | €12.99 | €13.08 | €12.79 | 0 | |
| €13.25 | +0.063 | +0.5% | €13.28 | €13.36 | €13.22 | 0 | |
| €13.19 | -0.011 | -0.1% | €13.21 | €13.22 | €13.13 | 0 | |
| €13.20 | -0.193 | -1.4% | €13.17 | €13.30 | €13.11 | 0 | |
| €13.40 | +0.35 | +2.7% | €13.48 | €13.51 | €13.32 | 0 | |
| €13.05 | +0.184 | +1.4% | €13.05 | €13.05 | €13.01 | 0 | |
| €12.86 | -0.177 | -1.4% | €13.32 | €13.39 | €12.80 | 81 | |
| €13.04 | +0.004 | 0.0% | €13.04 | €13.04 | €13.04 | 0 | |
| €13.03 | +0.003 | 0.0% | €13.02 | €13.10 | €13.02 | 0 | |
| €13.03 | -0.079 | -0.6% | €13.05 | €13.05 | €12.96 | 0 | |
| €13.11 | +0.158 | +1.2% | €13.13 | €13.13 | €13.07 | 0 | |
| €12.95 | -0.063 | -0.5% | €12.98 | €12.99 | €12.90 | 0 | |
| €13.02 | +0.046 | +0.4% | €13.07 | €13.08 | €12.92 | 0 | |
| €12.97 | -0.178 | -1.4% | €12.97 | €12.97 | €12.93 | 0 | |
| €13.15 | -0.159 | -1.2% | €13.18 | €13.19 | €13.12 | 0 |
- Ticker
- Frankfurt:ON4
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Latest deck · Oct 29, 2026
Q2 FY2027 Earnings Presentation
Earnings · 48 slides
Latest news
Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Oct 28, 2026
Closed €12.05 (-10.2%) on Oct 29, 2026
2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS)
Oct 28, 2026
Closed €12.05 (-10.2%) on Oct 29, 2026
ONO Pharmaceutical: Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN Countries
Oct 8, 2026
Closed €12.20 (+0.2%) on Oct 8, 2026
Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Oct 8, 2026
Closed €12.20 (+0.2%) on Oct 8, 2026
ONO Pharmaceutical: Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures, With or Without Secondary Generalized Seizures
Sep 16, 2026
Closed €12.49 (-0.6%) on Sep 16, 2026
Kaneka Ubiquinol™ memenangi nutraingredients Asia Ingredient of the Year: healthspan Award 2026
Sep 8, 2026
Closed €12.87 (-2.9%) on Sep 9, 2026
Issued by another party
OPDIVO® Intravenous Infusion Approved in Taiwan for the Treatment of Resectable Non-Small Cell Lung Cancer with Neoadjuvant OPDIVO in Combination with Chemotherapy Followed by Surgery and Adjuvant Single-Agent OPDIVO
Aug 19, 2026
Closed €13.31 (+2.7%) on Aug 19, 2026
ONO Pharmaceutical: Continues to be Selected for ESG Investment Indexes Adopted by GPIF
Aug 17, 2026
Closed €12.79 (-1.5%) on Aug 17, 2026
Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Jul 30, 2026
Closed €12.65 (-3.1%) on Jul 31, 2026
ONO Pharmaceutical Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 30 in the last 12 months · 40 in all · newest Oct 29, 2026 · oldest 2025
- Decks
- 39 decks · latest Oct 29, 2026
Where ONO Pharmaceutical Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4528 小野薬品工業 · Home listing | Tokyo | Japan | JPY |
| OTC:OPHLY | OTC | United States | USD |
| LS Exchange:859650 | LS Exchange | Germany | EUR |
| Lang & Schwarz:859650 | Lang & Schwarz | Germany | EUR |
| BMV:4528N | BMV | Mexico | MXN |
| gettex:ON4 | gettex | Germany | EUR |
| OTC:OPHLF | OTC | United States | USD |
| Dusseldorf:ON4 | Dusseldorf | Germany | EUR |
| Frankfurt:ON4 · This page | Frankfurt | Germany | EUR |
| BIVA:4528N | BIVA | Mexico | MXN |
| gettex:ON40 | gettex | Germany | EUR |
| Lang & Schwarz:A2N6NC | Lang & Schwarz | Germany | EUR |
| Munich:ON4 | Munich | Germany | EUR |
| Munich:ON40 | Munich | Germany | EUR |
| Stuttgart:ON4 | Stuttgart | Germany | EUR |
| Tradegate:ON4 | Tradegate | Germany | EUR |
| Hamburg:ON4 | Hamburg | Germany | EUR |
| Hanover:ON4 | Hanover | Germany | EUR |
Team and board
| Officer | Role |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 FY2027 Earnings Presentation | Earnings | 48 slides | Oct 29, 2026 |
| Q1 FY2027 Earnings Presentation | Earnings | 31 slides | Jul 31, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| Investor Day (June 2026) | Investor day | 61 slides | Jun 8, 2026 |
| FY2025 Earnings Presentation | Earnings | 48 slides | May 8, 2026 |
| ESG Presentation (March 2026) | Sustainability | 31 slides | Mar 24, 2026 |
| Investor Day (March 2026) | Investor day | 31 slides | Mar 24, 2026 |
| Q3 FY2025 Earnings Presentation | Earnings | 36 slides | Feb 2, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 30 slides | Jan 14, 2026 |
| Q2 FY2025 Earnings Presentation | Earnings | 54 slides | Oct 30, 2025 |
All 39 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 FY2025 Earnings Presentation | Earnings | 37 slides | Aug 1, 2025 |
| Investor Presentation (June 2025) | Investor deck | 9 slides | Jun 19, 2025 |
| Investor Day (June 2025) | Investor day | 15 slides | Jun 4, 2025 |
| Investor Day (May 2025) | Investor day | 39 slides | May 20, 2025 |
| FY2024 Earnings Presentation | Earnings | 44 slides | May 8, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| ESG Presentation (March 2025) | Sustainability | 34 slides | Mar 5, 2025 |
| Q3 FY2024 Earnings Presentation | Earnings | 46 slides | Feb 3, 2025 |
| Q2 FY2024 Earnings Presentation | Earnings | 51 slides | Nov 1, 2024 |
| Q1 FY2024 Earnings Presentation | Earnings | 35 slides | Jul 31, 2024 |
| FY2023 Earnings Presentation | Earnings | 40 slides | May 10, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| Merger or Acquisition (April 2024) | Merger or acquisition | 27 slides | Apr 30, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| ESG Presentation (March 2024) | Sustainability | 47 slides | Mar 26, 2024 |
| Technical Presentation (February 2024) | Technical | 65 slides | Feb 22, 2024 |
| Investor Day (February 2024) | Investor day | 65 slides | Feb 22, 2024 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| ESG Presentation (March 2023) | Sustainability | 48 slides | Mar 28, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| Technical Presentation (February 2023) | Technical | 51 slides | Feb 24, 2023 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| ESG Presentation (March 2022) | Sustainability | 44 slides | Mar 28, 2022 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| Technical Presentation (September 2021) | Technical | 31 slides | Sep 7, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2021) | Sustainability | 42 slides | Mar 22, 2021 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
| ESG Presentation (March 2020) | Sustainability | 50 slides | Mar 24, 2020 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| 2nd Quarter of Fiscal Year 2026 (Ending March 31, 2027) (April 1, 2026 to September 30, 2026) Supplementary Materials (Consolidated IFRS) | Oct 28, 2026 | Results | Tokyo Stock Exchange |
| Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN | Oct 8, 2026 | Acquisition or disposal | Tokyo Stock Exchange |
| Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS) | Jul 30, 2026 | Results | Tokyo Stock Exchange |
Cap table
Built by 6ix from ONO Pharmaceutical Co., Ltd.’s releases
- Common shares
- 498,692,800
- Fully diluted
- 498,692,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 498,692,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 498,692,800 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ono Pharmaceutical Co | Corporate Communications · Since at least May 27, 2026 |
Log in to ask 6ix AI your own questions about ONO Pharmaceutical Co., Ltd.